A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
Clinical trial NCT00694785 · WITHDRAWN
Trial details
- NCT number
- NCT00694785
- Sponsor
- Archemix Corp.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-06-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.